Results 141 to 150 of about 26,585 (198)

Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation. [PDF]

Pharmacol Rep
Rakowska A, Dutkiewicz M, Zegrocka-Stendel O, Dymkowska D, Huszcza G, Wierzbicki M, Walczak J, Rudnicka L, Koziak K.   +8 more
europepmc   +1 more source

Direct-to-Consumer Teledermatology for Male Androgenetic Alopecia: Narrative Review. [PDF]

JMIR Dermatol
Abeck F, Hansen-Abeck I, Kött J, Garrahy E, Schneider SW, von Büren J.   +5 more
europepmc   +1 more source

Risk factors for androgenetic alopecia: a systematic review and meta-analysis. [PDF]

BMC Public Health
Li H, Li W, Zhang J, Liang Q, Zhao Y, Guo Z, Jiang B, Wang Z, Qu Q, An S, Miao Y.   +10 more
europepmc   +1 more source

RETRACTION: Clinical Efficacy and Mechanisms of Microneedling Alone or Combined With Drugs in the Treatment of Androgenetic Alopecia. [PDF]

J Cosmet Dermatol
europepmc   +1 more source